Further to intimation dated May 07, 2026, Caplin Point Laboratories has informed that the Board of Directors, at its meeting held today, has declared an Interim Dividend of Rs 4.00 (200%) per equity share of face value of Rs 2 each for the financial year ended March 31, 2026; fixed May 30, 2026 as Record Date for determining the eligibility of the Shareholders for the purpose of Interim Dividend; approved the Audited standalone and consolidated financial results (including segment reporting for the consolidated results) of the Company for the year ended March 31, 2026, along with Auditors Report (Annexure-1). They also enclosed a Press Release issued by the Company (Annexure-2) and an investor presentation in this regard (Annexure-3); approved amendments to Code of Practices and Procedure for Fair Disclosure of Unpublished Price Sensitive Information. The aforesaid code has been made available on the website of the Company at https://www.caplinpoint.net/index.php/corporate-governance/ They are also enclosing the information w.r.t. Large Corporate as Annexure -4. They confirmed and declared that the Statutory Auditors of the Company i.e., Brahmayya & Co, Chartered Accountants, have issued the audit report on Standalone and Consolidated Financial Statements of the Company for the year ended March 31, 2026, with unmodified opinion. The meeting commenced at 11.10 AM and concluded at 1.10 PM.
The above information is a part of company’s filings submitted to BSE.
